Mark has worked in the pharmaceutical services field for the past 13 years, after receiving his BSc and D.Phil. at Oxford University, completing post-doctoral studies at Yale University, and achieving a distinction in his MBA at Warwick University.
Conversis Medical appoints Dr Mark Hooper as Global Director
Mark has worked in the pharmaceutical services field for the past 13 years, after receiving his BSc and D.Phil. at Oxford University, completing post-doctoral studies at Yale University, and achieving a distinction in his MBA at Warwick University.
Tags
Related posts
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
